Medicare Spending on Drugs With Accelerated Approval, 2015-2019

This article examines the budgetary implications of high-priced accelerated approval drugs by estimating Medicare spending on these drugs from 2015 through 2019.

Detalles Bibliográficos
Autores principales: Rome, Benjamin N., Feldman, William B., Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796889/
https://www.ncbi.nlm.nih.gov/pubmed/35977299
http://dx.doi.org/10.1001/jamahealthforum.2021.3937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796889/
https://www.ncbi.nlm.nih.gov/pubmed/35977299
http://dx.doi.org/10.1001/jamahealthforum.2021.3937

Ejemplares similares